News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

XTend Medical (XMDC.PK) Begins Process to Change Name to MultiCorp International, Inc.



4/27/2012 9:39:06 AM

SUN VALLEY, CA--(Marketwire - April 27, 2012) -

XTend Medical, (PINKSHEETS: XMDC), has begun the process to change their name from XTend Medical Corporation to MultiCorp International, Inc. Upon final approval from FINRA and other regulatory agencies, the name change will be effective as soon as possible.

The company released the following statement:

"The decision to change the name of the company to MultiCorp International, Inc. is based on the company's plans to acquire companies that have opportunities in many varying sectors in today's business world. The company will continue to be deeply involved in the medical field. However, other opportunities have presented themselves that will further build our core value of growth and bring value to the company. The share structure will remain intact and no reverse split or any other changes will be made to the company," stated Paul D. Lisenby, CEO of XTend Medical.

Mr. Lisenby further added, "All of the acquisitions targeted will have seasoned management running these companies. Their experience, along with the structure and contacts our company brings, will allow them to prosper and grow. Our company is moving forward and will continue to capitalize on opportunities presented that make sound sense."

About XTend Medical

XTend Medical/MultiCorp International, Inc. is a company that operates its core business in the medical field but will also have divisions within the company in varying business sectors. The company will continue to capitalize on growth sectors with solid business models and management that have the potential to grow exponentially. For further information please contact them at info@xtendmedical.com

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.


CONTACT
XTend Medical
info@xtendmedical.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES